Adjustment for baseline covariates: an introductory note

被引:17
作者
Grouin, JM
Day, S
Lewis, J
机构
[1] Hatch Green Cottage, Canterbury CT4 7LP, Kent, England
[2] Univ Rouen, F-78810 Feucherolles, France
[3] MHRA, London SW8 5NQ, England
关键词
D O I
10.1002/sim.1646
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The purpose of this note is to provide the background to the material covered by the most recently adopted Committee on Proprietary Medicinal Products (CPMP) Points to Consider (PtC) document, the fifth in the series. This is a regulatory guideline on the topic of adjustment for baseline covariates in controlled clinical trials. It is reproduced in the following pages of this journal. © 2004 John Wiley & Sons, Ltd.
引用
收藏
页码:697 / 699
页数:3
相关论文
共 10 条
[1]  
[Anonymous], 1999, STAT MED, V18, P1905
[2]  
CPMP, 2001, BRIT J CLIN PHARMACO, V52, P223
[3]  
*CPMP, 2001, CPMPEWP177699 EMEA
[4]  
*CPMP, 2001, CPMPEWP245902 EMEA
[5]  
*CPMP, 2002, CPMPEWP90899 EMEA
[6]  
*CPMP, 1999, CPMPEWP215899 EMEA
[7]  
CPMP, 2003, CPMPEWP286399 EMEA
[8]  
*CPMP, 2002, CPMPEWP245902 EMEA
[9]  
Lewis JA, 1999, STAT MED, V18, P1903, DOI 10.1002/(SICI)1097-0258(19990815)18:15<1903::AID-SIM188>3.3.CO
[10]  
2-6